Analyzing the Effects of Psychotropic Drugs on Metabolite Profiles in Rat Brain Using1H NMR Spectroscopy

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Nicholson, J. K., Lindon, J. C., & Holmes, E. C. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,903 · see citing works

Orthogonal projections to latent structures (O‐PLS)

Trygg, J., & Wold, S. (2002) · Journal of Chemometrics · doi:10.1002/cem.695 · Cited by 2,489 · see citing works

Brain maps: structure of the rat brain

Guillery, R. W. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90187-q · Cited by 1,677 · see citing works

Glial reduction in the subgenual prefrontal cortex in mood disorders

Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · see citing works

N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology

MOFFETT, J., Ross, B., Arun, P., Madhavarao, C. N., & Namboodiri, A. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.003 · Cited by 1,413 · see citing works

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

Prabakaran, S., SWATTON, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M. T., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 973 · see citing works

Multinuclear NMR Studies on the Energy Metabolism of Glial and Neuronal Cells

Brand, A., Richter‐Landsberg, C., & Leibfritz, D. (1994) · Developmental Neuroscience · doi:10.1159/000111347 · Cited by 889 · see citing works

Neuron-glia metabolic coupling and plasticity

Magistretti, P. J. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2010.053157 · Cited by 739 · see citing works

Mitochondrial dysfunction and molecular pathways of disease

Pieczenik, S. R., & Neustadt, J. O. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.09.008 · Cited by 638 · see citing works

Multivariate Data Analysis in Chemistry

Wold, S., Albano, C., Dunn, W. J., Edlund, U. G., Esbensen, K. H., Geladi, P. L. M., Hellberg, S., Johansson, E., Lindberg, W., & Sjöstróm, M. (1984) · Springer eBooks · doi:10.1007/978-94-017-1026-8_2 · Cited by 629 · see citing works

Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder

Konradi, C. L., Eaton, M. E., MacDonald, M. L., Walsh, J. P., Benes, F. M., & Heckers, S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.300 · Cited by 499 · see citing works

Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research

Stork, C., & Renshaw, P. F. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001711 · Cited by 486 · see citing works

Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia

Horáček, J., Bubeníková‐Valešová, V., Kopeček, M., Páleníček, T., Dockery, C. A., Mohr, P., & Höschl, C. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00004 · Cited by 462 · see citing works

Glutamate and Glutamine Measured With 4.0 T Proton MRS in Never-Treated Patients With Schizophrenia and Healthy Volunteers

Théberge, J., Bartha, R., Drost, D. J., Menon, R. S., MALLA, A. K., Takhar, J., Neufeld, R. W. J., Rogers, J. S., Pavlosky, W. F., Schaefer, B., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1944 · Cited by 398 · see citing works

Mechanisms of Action of Antiepileptic Drugs

Czapiński, P., Błaszczyk, B., & Czuczwar, S. J. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053386962 · Cited by 394 · see citing works

N-Acetylaspartate in the Vertebrate Brain: Metabolism and Function

Baslow, M. H. (2003) · Neurochemical Research · doi:10.1023/a:1023250721185 · Cited by 393 · see citing works

Valproate: Past, Present, and Future

Johannessen, C. U., & Johannessen, S. I. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00249.x · Cited by 363 · see citing works

Effects of Antipsychotic Drugs on Extracellular Dopamine Levels in Rat Medial Prefrontal Cortex and Nucleus Accumbens

Kuroki, T., Meltzer, H. Y., & Ichikawa, J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38019-x · Cited by 351 · see citing works

Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia

Holmes, E. C., Tsang, T. M., Huang, J. T.-J., Leweke, F. M., Koethe, D., Gerth, C. W., Nolden, B. M., Gross, S., Schreiber, D., Nicholson, J. K., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030327 · Cited by 292 · see citing works

Schizophrenia: from phenomenology to neurobiology

Wong, A. H. C., & Tol, H. H. M. V. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00035-6 · Cited by 282 · see citing works

Molecular Mechanisms of Schizophrenia

Lang, U. E., Puls, I., Müller, D. J., Strutz‐Seebohm, N., & Gallinat, J. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110430 · Cited by 281 · see citing works

Glutamate and Glutamine in the Anterior Cingulate and Thalamus of Medicated Patients With Chronic Schizophrenia and Healthy Comparison Subjects Measured With 4.0-T Proton MRS

Théberge, J., Al-Semaan, Y. M., Williamson, P., Menon, R. S., Neufeld, R. W. J., Rajakumar, N., Schaefer, B., Densmore, M., & Drost, D. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2231 · Cited by 269 · see citing works

Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo‐controlled trials

Smith, L. A., Cornelius, V. R., Warnock, A., Tacchi, M. J., & Taylor, D. M. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00468.x · Cited by 269 · see citing works

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: A systematic review of the in vivo proton magnetic resonance spectroscopy findings

Yildiz-Yesiloglu, A., & Ankerst, D. P. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.03.012 · Cited by 253 · see citing works

The cognitive and neurophysiological basis of emotion dysregulation in bipolar disorder.

Green, M., Cahill, C., & Malhi, G. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.024 · Cited by 247 · see citing works

Choline, myo‐inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex

Moore, C. M., Breeze, J. L., Gruber, S. A., Babb, S. M., Frederick, B. B., Villafuerte, R. A., Stoll, A. L., Hennen, J. A., Yurgelun-Todd, D. A., Cohen, B. M., et al. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.20302.x · Cited by 197 · see citing works

Neurochemical Effects of Olanzapine in First-Hospitalization Manic Adolescents: A Proton Magnetic Resonance Spectroscopy Study

DelBello, M. P., Cecil, K. M., Adler, C. M., Daniels, J. P., & Strakowski, S. M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300950 · Cited by 143 · see citing works

Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients

Silverstone, P. H., Wu, R., O'Donnell, T., Ulrich, M., Asghar, S., & Hanstock, C. C. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00002 · Cited by 135 · see citing works

What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update

Abbott, C., & Bustillo, J. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000214337.29378.cd · Cited by 133 · see citing works

Prospective multiaxial motion correction for fMRI

Ward, H. A., Riederer, S. J., Grimm, R. C., Ehman, R. L., Felmlee, J. P., & Jack, C. R. (2000) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(200003)43:3 · Cited by 132 · see citing works

CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis

Huang, J. T.-J., Leweke, F. M., Tsang, T. M., Koethe, D., Kranaster, L., Gerth, C. W., Gross, S., Schreiber, D., Ruhrmann, S., Schultze‐Lutter, F., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000756 · Cited by 127 · see citing works

Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: Implications for the pathophysiology of psychiatric disorders

Thomas, E. A., Dean, B., Pavey, G., & Sutcliffe, J. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071056198 · Cited by 127 · see citing works

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study

Ohrmann, P., Siegmund, A., Suslow, T., Pedersen, A., Spitzberg, K., Kersting, A., Rothermundt, M., Arolt, V., Heindel, W., & Pfleiderer, B. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.002 · Cited by 116 · see citing works

Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication‐free individuals with bipolar disorder: an in vivo1H MRS study

Frey, B. N., Stanley, J. A., Nery, F. G., Monkul, E. S., Nicoletti, M., Chen, H., Hatch, J. P., Caetano, S. C., Ortíz, O., Kapczinski, F. P., et al. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00454.x · Cited by 113 · see citing works

Brain Metabolite Abnormalities in the White Matter of Elderly Schizophrenic Subjects: Implication for Glial Dysfunction

Chang, L., Friedman, J. I., Ernst, T., Zhong, K., Tsopelas, N. D., & Davis, K. L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.025 · Cited by 101 · see citing works

Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia

Tkachev, D., Mimmack, M. L., Huffaker, S. J., Ryan, M., & Bahn, S. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706007334 · Cited by 101 · see citing works

Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study

Ohrmann, P., Siegmund, A., Suslow, T., Spitzberg, K., Kersting, A., Arolt, V., Heindel, W. L., & Pfleiderer, B. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.08.021 · Cited by 100 · see citing works

The application of NMR-based metabonomics in neurological disorders

Holmes, E. C., Tsang, T. M., & Tabrizi, S. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.004 · Cited by 92 · see citing works

Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confounds

Halim, N. D., Lipska, B. K., Hyde, T. M., Deep‐Soboslay, A., Saylor, E., Herman, M. M., Thakar, J. H., Verma, A. M., & Kleinman, J. E. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.11.017 · Cited by 91 · see citing works

Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia

du Bois, T. M., Deng, C., & Huang, X. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.034 · Cited by 91 · see citing works

Dysregulation of GABAergic Neurotransmission in Mood Disorders

Bielau, H., Steiner, J. H., Mawrin, C., Trübner, K., Brisch, R., Meyer-Lotz, G., Brodhun, M., Dobrowolny, H., Baumann, B., Gos, T., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.081 · Cited by 90 · see citing works

ARIPIPRAZOLE: A REVIEW OF ITS PHARMACOLOGY AND CLINICAL USE

Taylor, D. M. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb11397.x · Cited by 88 · see citing works

Treatment of bipolar depression: An update

Fountoulakis, K. Ν., Grunze, H., Panagiotidis, P., & Kaprinis, G. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.10.016 · Cited by 87 · see citing works

The role of lactate in brain metabolism

Fillenz, M. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.05.011 · Cited by 87 · see citing works

Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics

Lublin, H., Eberhard, J., & Levander, S. E. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200507000-00001 · Cited by 87 · see citing works

Gene Expression Profiling in Schizophrenia and Related Mental Disorders

Iwamoto, K., & Kato, T. (2006) · The Neuroscientist · doi:10.1177/1073858406287536 · Cited by 86 · see citing works

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study

Sigmundsson, T., Maier, M., Toone, B., Williams, S., Simmons, A., Greenwood, K., & Ron, M. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00533-9 · Cited by 78 · see citing works

Aripiprazole acts as a selective dopamine D2receptor partial agonist

Wood, M. D., & Reavill, C. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.6.771 · Cited by 78 · see citing works

Proton Magnetic Resonance Spectroscopy During Initial Treatment With Antipsychotic Medication in Schizophrenia

Bustillo, J., Rowland, L. M., Jung, R. E., Brooks, W. M., Qualls, C., Hammond, R., Hart, B. L., & Lauriello, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301631 · Cited by 73 · see citing works

The Effect of Risperidone on Metabolite Measures in the Frontal Lobe, Temporal Lobe, and Thalamus in Schizophrenic Patients. A Proton Magnetic Resonance Spectroscopy (1H MRS) Study

Szulc, A., Galińska-Skok, B., Tarasów, E., Dzienis, W., Kubas, B., Konarzewska, B., Walecki, J. M., Alathiaki, A. S., & Czernikiewicz, A. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-873156 · Cited by 72 · see citing works

Metabolic characterization of distinct neuroanatomical regions in rats by magic angle spinning 1H nuclear magnetic resonance spectroscopy

Tsang, T. M., Griffin, J. L., Haselden, J. N., Fish, C., & Holmes, E. C. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20447 · Cited by 67 · see citing works

Neuron–astrocyte interactions in the regulation of brain energy metabolism: a focus on NMR spectroscopy

Escartin, C., Valette, J., Lebon, V., & Bonvento, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04083.x · Cited by 63 · see citing works

Time-Dependent Cognitive Deficits Associated with First and Second Generation Antipsychotics: Cholinergic Dysregulation as a Potential Mechanism

Terry, A. V., & Mahadik, S. P. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106047 · Cited by 63 · see citing works

Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications

Mahadik, S. P., & Evans, D. R. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00033-3 · Cited by 62 · see citing works

The neurobiology of treatment response to antidepressants and mood stabilizing medications

Young, L. T., Bakish, D., & Beaulieu, S. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0244 · Cited by 61 · see citing works

Metabolic Profiling of Plasma from Discordant Schizophrenia Twins: Correlation between Lipid Signals and Global Functioning in Female Schizophrenia Patients

Tsang, T. M., Huang, J. T.-J., Holmes, E. C., & Bahn, S. (2006) · Journal of Proteome Research · doi:10.1021/pr0503782 · Cited by 61 · see citing works

Energy substrates to support glutamatergic and GABAergic synaptic function: Role of glycogen, glucose and lactate

Schousboe, A., Bak, L. K., Sickmann, H. M., Sonnewald, U., & Waagepetersen, H. S. (2007) · Neurotoxicity Research · doi:10.1007/bf03033909 · Cited by 56 · see citing works

A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis

Wood, S. J., Berger, G. E., Wellard, R. M., Proffitt, T., McConchie, M., Velakoulis, D., McGorry, P. D., & Pantelis, C. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.03.012 · Cited by 56 · see citing works

Treatment of psychosis: 30 years of progress

de Oliveira, I. R., & Juruena, M. F. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00784.x · Cited by 55 · see citing works

Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy

Kim, D. J., Lyoo, I. K., Yoon, S. J., Choi, T., Lee, B., Kim, J. E., Lee, J. S., & Renshaw, P. F. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.04.009 · Cited by 54 · see citing works

Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine

Atmaca, M., Yıldırım, H., Özdemir, H., Oğur, E., & Tezcan, E. (2006) · Psychological Medicine · doi:10.1017/s0033291706008968 · Cited by 51 · see citing works

Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol

Harte, M., Bachus, S. B., & Reynolds, G. P. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.11.001 · Cited by 51 · see citing works

Pharmacotherapy of ADHD in Adults

Wilens, T. E. (2008) · CNS Spectrums · doi:10.1017/s1092852900002960 · Cited by 50 · see citing works

Long-Term Treatment of Rats with Haloperidol: Lack of an Effect on Brain N-Acetyl Aspartate Levels

Bustillo, J., Barrow, R., Paz, R. D., Tang, J., Seraji‐Bozorgzad, N., Moore, G. J., Bolognani, F., Lauriello, J., Perrone‐Bizzozero, N. I., & Galloway, M. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300874 · Cited by 42 · see citing works

Novel Targets for Drugs in Schizophrenia

Stone, J. M., & Pilowsky, L. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707781387323 · Cited by 39 · see citing works

Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex

Huang, M., Li, Z., Ichikawa, J., Dai, J., & Meltzer, H. Y. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.081 · Cited by 38 · see citing works

Molecular Profiling of Antipsychotic Drug Function: Convergent Mechanisms in the Pathology and Treatment of Psychiatric Disorders

Thomas, E. A. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:2:109 · Cited by 38 · see citing works

Anticonvulsant, antiepileptogenic, and antiictogenic pharmacostrategies

Holtkamp, M., & Meierkord, H. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7021-2 · Cited by 35 · see citing works

Clinical applications of MR spectroscopy in epilepsy

Kuzniecky, R. (2004) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2004.04.010 · Cited by 33 · see citing works

Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: In vitro binding studies and positron emission tomography

Mach, R. H., Nader, M. A., Ehrenkaufer, R. L., Line, S. W., Smith, C. R., Luedtke, R. R., Kung, M., Kung, H. F., Huston-Lyons, D., & Morton, T. E. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199612)24:4 · Cited by 30 · see citing works

Update on the Etiology and Treatment of Schizophrenia and Bipolar Disorder

Buckley, P. F. (2008) · CNS Spectrums · doi:10.1017/s1092852900028212 · Cited by 29 · see citing works

13C Magnetic Resonance Spectroscopy Studies of Alterations in Glutamate Neurotransmission

Shen, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.042 · Cited by 27 · see citing works

Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder

Crespo, F. S., Luque, R., Prieto‐Merino, D., Sau, P., Albert, C., Leal, I., de Luxan, A., Osuna, M. I., Ruiz, M., Galán, R., et al. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0808-9 · Cited by 23 · see citing works

Historical Review of Carbamazepine for the Treatment of Bipolar Disorder

Stoner, S. C., Nelson, L. A., Lea, J. W., Marken, P. A., Sommi, R. W., & Dahmen, M. M. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.1.68 · Cited by 23 · see citing works

Olanzapine: an atypical antipsychotic for schizophrenia

Lund, B. C., & Perry, P. J. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.2.305 · Cited by 23 · see citing works

Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats

Levant, B., Crane, J. F., & Carlson, S. E. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.034 · Cited by 20 · see citing works

Metabolic Parameters of Epilepsy: Adjuncts to Established Antiepileptic Drug Therapy

van Gelder, N. M., & Sherwin, A. L. (2003) · Neurochemical Research · doi:10.1023/a:1022433421761 · Cited by 10 · see citing works

Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies

Marsman, A., van den Heuvel, M. P., Klomp, D. W. J., Kahn, R. S., Luijten, P. R., & Hulshoff Pol, H. E. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr069 · Cited by 457 · see citing works

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy

Mao, X. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1519 · Cited by 296 · see citing works

Neurometabolites in schizophrenia and bipolar disorder — A systematic review and meta-analysis

Kraguljac, N. V., Reid, M. A., White, D. M., Jones, R., den Hollander, J., Lowman, D., & Lahti, A. C. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.02.003 · Cited by 204 · see citing works

Gallic Acid Ameliorated Impaired Glucose and Lipid Homeostasis in High Fat Diet-Induced NAFLD Mice

Chao, J., Huo, T., Cheng, H.-Y., Tsai, J.-C., Liao, J., Lee, M., Qin, X.-M., Hsieh, M., Pao, L., & Peng, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096969 · Cited by 169 · see citing works

Metabolomics analysis I. Selection of biological samples and practical aspects preceding sample preparation

Álvarez-Sánchez, B., Priego‐Capote, F., & de Castro, M. D. L. (2009) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2009.12.003 · Cited by 169 · see citing works

Anterior Cingulate Glutamate Levels Related to Clinical Status Following Treatment in First-Episode Schizophrenia

Egerton, A., Brugger, S. P., Raffin, M., Barker, G. J., Lythgoe, D. J., McGuire, P. K., & Stone, J. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.113 · Cited by 168 · see citing works

GABA and glutamate in schizophrenia: A 7 T 1H-MRS study

Marsman, A., Mandl, R. C. W., Klomp, D. W. J., Bohlken, M. M., Boer, V. O., Андрейченко, А. Е., Cahn, W., Kahn, R. S., Luijten, P. R., & Pol, H. E. H. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.10.005 · Cited by 151 · see citing works

Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)

Egerton, A., Broberg, B. V., van Haren, N. E. M., Merritt, K., Barker, G. J., Lythgoe, D. J., Pérez‐Iglesias, R., Baandrup, L., Düring, S. W., Sendt, K.-V., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0082-9 · Cited by 127 · see citing works

Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders

Sethi, S., & Brietzke, E. M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv096 · Cited by 122 · see citing works

Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies

Harris, L. W., Guest, P. C., Wayland, M. T., Umrania, Y., Krishnamurthy, D., Rahmoune, H., & Bahn, S. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.009 · Cited by 97 · see citing works

Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia

de Bartolomeis, A., Vellucci, L., Barone, A., Manchia, M., Luca, V. D., Iasevoli, F., & Correll, C. U. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108236 · Cited by 88 · see citing works

Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients

Chan, M. K., Tsang, T. M., Harris, L. W., Guest, P. C., Holmes, E. C., & Bahn, S. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.100 · Cited by 85 · see citing works

Regional Decoupling of N-acetyl-aspartate and Glutamate in Schizophrenia

Kraguljac, N. V., Reid, M. A., White, D. M., den Hollander, J., & Lahti, A. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.126 · Cited by 84 · see citing works

Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies

Egerton, A., Bhachu, A., Merritt, K., McQueen, G., Szulc, A., & McGuire, P. K. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00066 · Cited by 84 · see citing works

Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia

McQueen, G., Sendt, K.-V., Gillespie, A. L., Avila, A., Lally, J., Vallianatou, K., Chang, N., Ferreira, D., Borgan, F., Howes, O. D., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa156 · Cited by 69 · see citing works

Quantification of High-Resolution 1H-[13C] NMR Spectra from Rat Brain Extracts

de Graaf, R. A., Chowdhury, G. M. I., & Behar, K. L. (2014) · Analytical Chemistry · doi:10.1021/ac5006926 · Cited by 63 · see citing works

Concentrations of Cortical GABA and Glutamate in Young Adults With Autism Spectrum Disorder

Kolodny, T., Schallmo, M., Gerdts, J. A., Edden, R. A. E., Bernier, R., & Murray, S. O. (2020) · Autism Research · doi:10.1002/aur.2300 · Cited by 59 · see citing works

The role of proteomics in depression research

Martins‐de‐Souza, D., Harris, L. W., Guest, P. C., Turck, C. W., & Bahn, S. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0093-2 · Cited by 58 · see citing works

Quantification of High-Resolution1H NMR Spectra from Rat Brain Extracts

de Graaf, R. A., Chowdhury, G. M. I., & Behar, K. L. (2010) · Analytical Chemistry · doi:10.1021/ac102285c · Cited by 54 · see citing works

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

Egerton, A., & Stone, J. M. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800784961 · Cited by 49 · see citing works

Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions

Dumas, M., & Davidovic, L. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9578-5 · Cited by 46 · see citing works

Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure

McClay, J. L., Adkins, D. E., Vunck, S. A., Batman, A. M., Vann, R. E., Clark, S. L., Beardsley, P. M., & van den Oord, E. J. C. G. (2012) · Metabolomics · doi:10.1007/s11306-012-0456-y · Cited by 45 · see citing works

Metabolomics in Psychiatric Disorders: What We Learn from Animal Models

Humer, E. C., Probst, T., & Pieh, C. (2020) · Metabolites · doi:10.3390/metabo10020072 · Cited by 44 · see citing works

Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies

Kubota, M., Moriguchi, S., Takahata, K., Nakajima, S., & Horita, N. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.069 · Cited by 38 · see citing works

Complexity and pitfalls of mass spectrometry-based targeted metabolomics in brain research

Urban, M. J., Enot, D. P., Dallmann, G., Körner, L., Forcher, V., Enoh, P., Koal, T., Keller, M., & Deigner, H. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.07.002 · Cited by 38 · see citing works

Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology

Data-Franco, J., Singh, A., Popovic, D., Ashton, M., Berk, M., Vieta, E., Figueira, M. L., & Dean, O. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.004 · Cited by 38 · see citing works

Prefrontal GABA Levels Measured With Magnetic Resonance Spectroscopy in Patients With Psychosis and Unaffected Siblings

Marenco, S., Meyer, C., Kuo, S. S., van der Veen, J. W. C., Shen, J., DeJong, K. N., Barnett, A. S., Apud, J. A., Dickinson, D., Weinberger, D. R., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020190 · Cited by 37 · see citing works

Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration

Egerton, A., Griffiths, K., Casetta, C., Deakin, J. F. W., Drake, R., Howes, O. D., Kassoumeri, L., Khan, S., Lankshear, S., Lees, J., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01508-w · Cited by 35 · see citing works

The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces in vivo Neuroreceptor Occupancy and Reduces Striatal Glutamate Levels

Bærentzen, S. L., Casado-Sainz, A., Lange, D., Shalgunov, V., Tejada, I. M., Xiong, M., L’Estrade, E. T., Edgar, F., Lee, H., Herth, M. M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00187 · Cited by 35 · see citing works

Behavioral and Molecular Biomarkers in Translational Animal Models for Neuropsychiatric Disorders

Sarnyai, Z., Alsaif, M., Bahn, S., Ernst, A., Guest, P. C., Hradetzky, E., Kluge, W. F., Stelzhammer, V., & Wesseling, H. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00008-0 · Cited by 35 · see citing works

Proteomic Technologies for Biomarker Studies in Psychiatry

Martins‐de‐Souza, D., Guest, P. C., Vanattou‐Saïfoudine, N., Harris, L. W., & Bahn, S. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-387718-5.00004-3 · Cited by 33 · see citing works

Deciphering the metabolic perturbation in hepatic alveolar echinococcosis: a 1H NMR-based metabolomics study

Lin, C., Chen, Z., Zhang, L., Wei, Z., Cheng, K., Liu, Y., Shen, G., Fan, H., & Dong, J. (2019) · Parasites & Vectors · doi:10.1186/s13071-019-3554-0 · Cited by 31 · see citing works

Proteomics as a Tool for Understanding Schizophrenia

Martins‐de‐Souza, D. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.3.95 · Cited by 28 · see citing works

Preclinical 1 H-Mrs Neurochemical Profiling in Neurological And Psychiatric Disorders

Lee, M. R., Đenić, A., Hinton, D. J., Mishra, P. K., Choi, D., Pirko, I., Rodriguez, M., & Macura, S. I. (2012) · Bioanalysis · doi:10.4155/bio.12.129 · Cited by 27 · see citing works

Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration

McClay, J. L., Vunck, S. A., Batman, A. M., Crowley, J. J., Vann, R. E., Beardsley, P. M., & van den Oord, E. J. C. G. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9605-1 · Cited by 27 · see citing works

Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography–tandem mass spectrometry

Kim, H.-Y., Rhee, S. J., Lee, H., Han, D., Lee, T. Y., Kim, M., Kim, E. Y., Kwon, J. S., Shin, H., Kim, H., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113850 · Cited by 25 · see citing works

Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia

Krajner, F., Hadaya, L., McQueen, G., Sendt, K.-V., Gillespie, A. L., Avila, A., Lally, J., Hedges, E. P., Diederen, K. M. J., Howes, O. D., et al. (2022) · Schizophrenia · doi:10.1038/s41537-022-00230-2 · Cited by 24 · see citing works

Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice

Picada, J. N., dos Santos, B. D. J. N., Celso, F. B., Monteiro, J. D., Rosa, K. M., Camacho, L. R., Vieira, L. R., Freitas, T. M., Silva, T. G. D., Pontes, V. M., et al. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.77 · Cited by 23 · see citing works

1H NMR-based metabolomics reveals neurochemical alterations in the brain of adolescent rats following acute methylphenidate administration

Quansah, E., Ruiz‐Rodado, V., Grootveld, M. C., Probert, F., & Zetterström, T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.003 · Cited by 18 · see citing works

1 H NMR metabolomics to study the effects of diazepam on anisatin induced convulsive seizures

Li, P., Wei, D.-D., Wang, J., Yang, M., & Kong, L. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.08.029 · Cited by 18 · see citing works

Predictive protein markers for depression severity in mood disorders: A preliminary trans-diagnostic approach study

Lee, H., Rhee, S. J., Kim, J., Lee, Y., Kim, H.-Y., Lee, J., Lee, K., Shin, H., Kim, H., Lee, T. Y., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.07.041 · Cited by 16 · see citing works

Adsorptive Stripping Differential Pulse Voltammetric Determination of Risperidone with a Multi‐Walled Carbon Nanotube‐Ionic Liquid Paste Modified Glassy Carbon Electrode

Arvand, M., & Pourhabib, A. (2012) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.201200161 · Cited by 16 · see citing works

Metabolite abnormalities in psychosis risk: A meta-analysis of proton magnetic resonance spectroscopy studies

Wang, Y.-M., Xiao, Y., & Xie, W.-L. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102220 · Cited by 15 · see citing works

Aripiprazole and Riluzole treatment alters behavior and neurometabolites in young ADHD rats: a longitudinal 1H-NMR spectroscopy study at 11.7T

Rizzo, F. R., Abaei, A., Nespoli, E., Fegert, J. M., Hengerer, B., Rasche, V., & Boeckers, T. M. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.167 · Cited by 14 · see citing works

Metabonomic Studies of Schizophrenia and Psychotropic Medications: Focus on Alterations in CNS Energy Homeostasis

Ma, D., Guest, P. C., & Bahn, S. (2009) · Bioanalysis · doi:10.4155/bio.09.144 · Cited by 13 · see citing works

Transcriptomic Analysis in a Drosophila Model Identifies Previously Implicated and Novel Pathways in the Therapeutic Mechanism in Neuropsychiatric Disorders

Singh, P., Mohammad, F., & Sharma, A. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00161 · Cited by 13 · see citing works

Effects of Methylphenidate on the Dopamine Transporter and Beyond

Zetterström, T., Quansah, E., & Grootveld, M. C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_333 · Cited by 11 · see citing works

The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment

Jauhar, S., McCutcheon, R. A., Veronese, M., Borgan, F., Nour, M. M., Rogdaki, M., Pepper, F., Stone, J. M., Egerton, A., Vamvakas, G., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02479-2 · Cited by 11 · see citing works

Transcriptional Effects of Psychoactive Drugs on Genes Involved in Neurogenesis

Bortolasci, C. C., Spolding, B., Kidnapillai, S., Connor, T., Truong, T. T. T., Liu, Z. S.-J., Panizzutti, B., Richardson, M. F., Gray, L. J., Berk, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218333 · Cited by 11 · see citing works

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study

Grošić, V., Grošić, P. F., Kalember, P., Janović, M. B., Mihanović, M., Henigsberg, N., & Radoš, M. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s61415 · Cited by 11 · see citing works

Long term antipsychotic treatment does not alter metabolite concentrations in rat striatum: An in vivo magnetic resonance spectroscopy study

Lindquist, D. M., Dunn, R. S., & Cecil, K. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.02.019 · Cited by 10 · see citing works

Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients

Birur, B., Kraguljac, N. V., VerHoef, L., Morgan, C. J., Jindal, R. D., Reid, M. A., Luker, A. T., & Lahti, A. C. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0700-6 · Cited by 11 · see citing works

The Trajectory of Prefrontal GABA Levels in Initially Antipsychotic-Naïve Patients With Psychosis During 2 Years of Treatment and Associations With Striatal Cerebral Blood Flow and Outcome

Bojesen, K. B., Rostrup, E., Sigvard, A. K., Mikkelsen, M. E., Edden, R. A. E., Ebdrup, B. H., & Glenthoj, B. Y. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.12.002 · Cited by 8 · see citing works

New Pharmacological Interventions in Bipolar Disorder

Juruena, M. F., Jelen, L. A., Young, A. H., & Cleare, A. J. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_181 · Cited by 8 · see citing works

Metabolomic profiling relates tianeptine effectiveness with hippocampal GABA, myo-inositol, cholesterol, and fatty acid metabolism restoration in socially isolated rats

Perić, I., Lješević, M., Beskoski, V. P., Nikolic, M. R., & Filipović, D. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06180-y · Cited by 8 · see citing works

Alterations in blood proteins in the prodromal stage of bipolar II disorders

Lee, H., Han, D., Rhee, S. J., Kim, J., Lee, Y., Kim, E. Y., Park, D. Y., Roh, S., Baik, M., Jung, H. Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07160-0 · Cited by 7 · see citing works

Proteomic profiling in the progression of psychosis: Analysis of clinical high-risk, first episode psychosis, and healthy controls

Lee, H., Kim, M., Kim, S. H., Lee, J., Lee, T. Y., Rhee, S. J., Roh, S., Baik, M., Jung, H. Y., Kim, H., et al. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.11.031 · Cited by 5 · see citing works

Clozapine's Multiple Cellular Mechanisms: What Do We Know after More than Fifty Years? a Systematic Review and Critical Assessment of Translational Mechanisms Relevant for Innovative Strategies in Treatment-Resistant SchizophreniaPreprint

de Bartolomeis, A., Vellucci, L., Barone, A., Manchia, M., Luca, V. D., Iasevoli, F., & Correll, C. U. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4089530 · Cited by 4 · see citing works

The effects of dopamine receptor antagonist and partial agonist antipsychotics on the glutamatergic system: double-blind, randomised, placebo-controlled 1 H-MRS cross-over study in healthy volunteers

Zahid, U., Osugo, M., Selvaggi, P., Lythgoe, D. J., Fortunato, C., Diederen, K. M. J., Kiemes, A., Wall, M. B., Whitehurst, T., Onwordi, E. C., et al. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.10319 · Cited by 1 · see citing works

What Does Proteomics Tell Us About Schizophrenia

Martins-de-Souza, D., Gattaz, W., Schmitt, A., Maccarrone, G., Falkai, P., Bahn, S., Dias-Neto, E., & Turck, C. (2011) · Springer eBooks · doi:10.1007/978-94-007-0837-2_16 · Cited by 1 · see citing works

Current World Literature

(2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328338cade

Elevated glutamine but not glutamate is associated with clozapine eligibility in an early psychosis sample

Seward, M., Puiras, E., Toba-Oluboka, T., Crocker, C. E., Tibbo, P. G., & Dempster, K. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1762696

Étude par spectroscopie de résonance magnétique nucléaire (RMN) des modifications physico-chimiques provoquées par des traitements thermiques (« torréfactions ») de graines du caféier Coffea arabica L.

Febvay, L. (2019) · doi:10.70675/2a5f0c95z03f9z41c0zb62az8d56f7f2c370

Prospective multiaxial motion correction for fMRI

Ward, H. A., Riederer, S. J., Grimm, R. C., Ehman, R. L., Felmlee, J. P., & Jack, C. R. (2000) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(200003)43:3 · Cited by 132 · see citing works

[The influence of atypical antipsychotics on brain functioning in schizophrenia. A proton magnetic resonance study].

Szulc, A., Galińiska, B., Tarasów, E., Dzienis, W., Kubas, B., Konarzewska, B., Waszkiewicz, N., & Popławska, R. (2010) · PubMed · Cited by 4 · see citing works

Proton Magnetic Resonance Spectroscopy Changes After Antipsychotic Treatment

Szulc, A., Galińska-Skok, B., Waszkiewicz, N., Bibulowicz, D., Konarzewska, B., & Tarasów, E. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713804870783 · Cited by 31 · see citing works

Proton Magnetic Resonance Spectroscopy Study of Brain Metabolite Changes after Antipsychotic Treatment

Szulc, A., Galińska-Skok, B., Tarasów, E., Waszkiewicz, N., Konarzewska, B., Popławska, R., Bibulowicz, D., Simonienko, K., & Walecki, J. M. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1279739 · Cited by 51 · see citing works

Spatial pharmacometabolomic profiling of two antipsychotics reveals region-specific neurochemical alterations in the rat brain

Lee, Y., Dayanidhi, N., Loryan, I., Hammarlund‐Udenaes, M., Shariatgorji, R., Nilsson, A., Andrén, P. E., & Vallianatou, T. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e01101